Jason Dearling, PhD

Jason is a radiopharmacologist with more than 30 years of experience from academia, including University College London, Boston Children’s Hospital and Harvard Medical School. He has a distinguished track record in leading collaborations between industry, academic centers and hospitals around the impact of targeted radiation on the tumor microenvironment using in vitro and in vivo models, multiple drug modalities and radionuclides. He was previously assistant professor at Harvard Medical School. He earned a Ph.D. in biochemistry from the University of Kent and completed a fellowship at University College London.